Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Technology Combines Speed of Rapid Antigen Test with Accuracy of PCR Testing to Detect COVID-19 in 4 Minutes

By LabMedica International staff writers
Posted on 10 Feb 2022

Scientists have developed a new coronavirus test that is accurate as a polymerase chain reaction (PCR) lab test but gives results within four minutes.

The test developed by researchers at Fudan University (Shanghai, China) uses a hypersensitive electromechanical biosensor to detect nucleic acids that were earlier difficult to identify owing to their low concentration in test samples. The sensor which uses microelectronics to analyze genetic material from swabs could reduce the need for time-consuming lab tests for diagnosing COVID-19.

PCR tests are the most accurate and sensitive for detecting SARS-COV-2, the virus that causes COVID-19, although they can take several hours to deliver results. Rapid antigen tests are a quicker alternative and deliver results in 15 minutes but are less reliable than PCR tests which are more accurate due to their greater sensitivity. In comparison to PCR tests, antigen tests require a higher concentration of the virus to exhibit a positive result due to which they are more likely to show a false negative. Antigen tests look for pieces of virus-infected proteins, while PCR tests search for viral genetic material such as nucleic acids and RNA.

Currently, there is no technology that can properly detect COVID-infected nucleic acids and RNA without using extraction and amplification methods which require a lab environment. The new method that uses a hypersensitive electromechanical biosensor to detect nucleic acids offers speed, ease of operation, high sensitivity and portability. Portable tests based on this technology could be used for on-site COVID-19 testing at airports, clinics, emergency departments and at home, as well as for quickly diagnosing other types of diseases.

In a clinical trial of the new test, the researchers collected nasal samples from 33 PCR-positive COVID-19 patients, 23 PCR-negative patients, six influenza-positive patients and 25 healthy volunteers. The researchers found that the test accurately processed all the cases without any errors in less than four minutes. The trial was conducted on a small sample, and if the 100% accuracy rate was replicated in a larger test sample, then the new test could be a game changer in COVID-19 diagnosis.

"We implemented an electromechanical biosensor for the detection of SARS-CoV-2 into an integrated and portable prototype device, and show that it detected (virus RNA) in less than four minutes," the team said in a peer-reviewed article describing their molecular electromechanical system, or MolEMS, in the journal Nature Biomedical Engineering.

Related Links:
Fudan University 

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.